HLA-G inhibits the allogeneic proliferative response

This publication has 13 references indexed in Scilit:

• p49, a putative HLA class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamily
  European Journal of Immunology, 1998
• HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A
  Proceedings of the National Academy of Sciences, 1998
• HLA-G expression in melanoma: A way for tumor cells to escape from immunosurveillance
  Proceedings of the National Academy of Sciences, 1998
• Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis
  Proceedings of the National Academy of Sciences, 1997
• Identification of a Thymic Epithelial Cell Subset Sharing Expression of the Class Ib HLA-G Molecule with Fetal Trophoblasts
  The Journal of Experimental Medicine, 1997
• The α₁domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: Is HLA-G the public ligand for natural killer cell inhibitory receptors?
  Proceedings of the National Academy of Sciences, 1997
• Human Histocompatibility Leukocyte Antigen (HLA)-G Molecules Inhibit NKAT3 Expressing Natural Killer Cells
  The Journal of Experimental Medicine, 1997
• Protection from Natural Killer Cell-Mediated Lysis by HLA-G Expression on Target Cells
  Science, 1996
• Cellular immune recognition of HLA-G-expressing choriocarcinoma cell line JEG-3
  International Journal of Cancer, 1991
• Transfer and expression of three cloned human non-HLA-A,B,C class I major histocompatibility complex genes in mutant lymphoblastoid cells.
  Proceedings of the National Academy of Sciences, 1988